| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3139 | Brivaracetam | CHENGDA PHARMACEUTICALS CO., LTD. Jiashan CN | 100012006;100020624 | CEP 2024-227 - Rev 00 | 2025/12/22 | Valid | 22/12/2030 | Chemical | 2025/12/22 | New application|CEP granted|22/12/2025 | |
| 2778 | Sitagliptin phosphate monohydrate | WAVELENGTH ENTERPRISES LTD. Petah Tikva IL | 100018877;100092992 | CEP 2024-213 - Rev 00 | 2025/12/22 | Valid | 22/12/2030 | Chemical | 2025/12/22 | New application|CEP granted|22/12/2025 | |
| 2306 | Gemcitabine hydrochloride | RAVI BIOLIFE PRIVATE LIMITED Mumbai IN | 100048404;100086771 | CEP 2023-229 - Rev 01 | 2025/12/19 | Valid | 05/08/2029 | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Minor revision|Accepted - CEP remains valid|15/11/2024; New application|CEP granted|05/08/2024 |
|
| 1472 | Sodium hyaluronate, GS-100, intrinsic viscosity: 1.50 m3/kg; from fermentation; for parenteral administration, including intra-ocular use | KIKKOMAN BIOCHEMIFA CO. Noda City JP | 100039417;100087689 | CEP 2020-420 - Rev 01 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Renewal|CEP granted|19/12/2025; Minor revision|Accepted - CEP remains valid|24/04/2025; Notification|Accepted - CEP remains valid|03/05/2024; New application|CEP granted|03/03/2021 |
||
| 1362 | Prilocaine | SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City CN | 100048410;100080174 | CEP 2024-300 - Rev 00 | 2025/12/19 | Valid | 19/12/2030 | Chemical | 2025/12/19 | New application|CEP granted|19/12/2025 | |
| 3095 | Dabigatran etexilate mesilate, Micronised, non-micronised | ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City CN | 100012174;100018701 | CEP 2024-073 - Rev 02 | 2025/12/19 | Valid | 19/08/2030 | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Minor revision|CEP granted|06/11/2025; New application|CEP granted|19/08/2025 |
|
| 1425 | Fosfomycin trometamol | ZACH SYSTEM Avrillé FR | 100012282;100021396 | CEP 2020-370 - Rev 04 | 2025/12/19 | Valid | 02/09/2026 | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Notification|Accepted - CEP remains valid|02/04/2025; Minor revision|CEP granted|12/06/2024; Minor revision|CEP granted|03/07/2023; Notification|Accepted - CEP remains valid|25/11/2022; Minor revision|CEP granted|09/12/2021; New application|CEP granted|02/09/2021 |
|
| 2585 | Rizatriptan benzoate | EMCURE PHARMACEUTICALS LIMITED Pune IN | 100011677;100022690 | CEP 2019-095 - Rev 02 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Renewal|CEP granted|19/12/2025; Minor revision|CEP granted|29/01/2024 |
||
| 1378 | Valproic acid | ANJAN DRUG PRIVATE LIMITED Alathur IN | 100023458;100032594 | CEP 2003-174 - Rev 04 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Minor revision|Accepted - CEP remains valid|14/09/2023 |
||
| 2541 | Quetiapine Fumarate | ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City CN | 100039329;100061908 | CEP 2015-218 - Rev 01 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Minor revision|Accepted - CEP remains valid|18/12/2023; Renewal|CEP granted|15/02/2022; Minor revision|CEP granted|25/05/2021 |
||
| 15 | Calcium chloride dihydrate | Merck KGaA Darmstadt DE | 100000742;100006955 | CEP 2007-356 - Rev 02 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Notification|Accepted - CEP remains valid|02/07/2025 |
||
| 2777 | Pregabalin | KOPRAN RESEARCH LABORATORIES LIMITED Mumbai IN | 100033667;100081898 | CEP 2018-080 - Rev 04 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Renewal|Accepted - CEP remains valid|26/03/2025; Minor revision|CEP granted|14/10/2024; Major revision|CEP granted|16/09/2022; Minor revision|CEP granted|03/02/2021 |
||
| 1705 | Sertraline hydrochloride, Form I | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2008-019 - Rev 07 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Minor revision|CEP granted|19/12/2025; Minor revision|CEP granted|02/12/2024; Minor revision|Accepted - CEP remains valid|02/07/2024; Minor revision|CEP granted|07/02/2024; Major revision|Rejected|03/02/2023; Minor revision|Accepted - CEP remains valid|08/08/2022; Minor revision|Accepted - CEP remains valid|25/05/2022; Minor revision|Accepted - CEP remains valid|31/03/2022 |
||
| 691 | alpha-Tocopheryl acetate concentrate (powder form), 50 g per 100 g of concentrate | DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH | 100053293;100094111 | CEP 2019-086 - Rev 02 | 2025/12/19 | Valid | Chemical | 2025/12/19 | Renewal|CEP granted|19/12/2025; Notification|CEP granted|16/07/2025 |
||
| 2535 | Levetiracetam | CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad IN | 100053345;100094249 | CEP 2023-046 - Rev 02 | 2025/12/18 | Valid | 15/05/2029 | Chemical | 2025/12/18 | Minor revision|CEP granted|18/12/2025; Notification|CEP granted|17/06/2025; New application|CEP granted|15/05/2024 |
|
| 1556 | Piretanide, Micronised | ZENTIVA K.S. Prague CZ | 100004108;100097772 | CEP 2024-234 - Rev 01 | 2025/12/18 | Valid | 14/11/2030 | Chemical | 2025/12/18 | Administrative procedure|CEP granted|18/12/2025; New application|CEP granted|14/11/2025 |
|
| . | N-(Methylpolyoxyethylene oxycarbonyl)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, sodium salt | NOF CORP. Shibuya JP | 100013118;100097453 | CEP 2025-351 - Rev 00 | 2025/12/18 | Valid | 18/12/2030 | TSE | 2025/12/18 | New application|CEP granted|18/12/2025 | |
| 1281 | Aceclofenac | HENAN DONGTAI PHARM CO., LTD. Anyang CN | 100023192;100052097 | CEP 2023-072 - Rev 01 | 2025/12/18 | Valid | 25/07/2029 | Chemical | 2025/12/18 | Minor revision|CEP granted|18/12/2025; New application|CEP granted|26/07/2024 |
|
| 2258 | Olanzapine, Form-I, Micronised | CADILA PHARMACEUTICALS LIMITED Ankleshwar IN | 100003616;100000498 | CEP 2024-469 - Rev 00 | 2025/12/18 | Valid | 18/12/2030 | Chemical | 2025/12/18 | New application|CEP granted|18/12/2025 | |
| 926 | Levonorgestrel, Process 2 | INDUSTRIALE CHIMICA S.R.L. Saronno IT | 100011692;100020331 | CEP 2025-476 - Rev 00 | 2025/12/18 | Valid | 18/12/2030 | Chemical | 2025/12/18 | New application|CEP granted|18/12/2025 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号